Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 10, 2015

View Archived Issues

Daiichi Sankyo advances pipeline in first quarter of fiscal 2015

Simulation-guided DNA probes designed to improve specificity of NA hybridization

MedImmune and Amgen start phase IIa trial of AMG-557 in Sjogren's syndrome

Sunshine Lake Pharma develops FXa inhibitors

Wockhardt divulges beta-lactamase inhibitors

Euclises Pharmaceuticals designs COX-2 inhibitors/NO donors

4D Pharma and APC Microbiome Institute to investigate live biotherapeutics for autism

Kwang Dong licenses South Korean rights to Contrave

Ono Pharmaceutical reviews events of first quarter of fiscal 2015

Celsion provides update on phase III trials of ThermoDox in HCC

LSK BioPharma in-licenses BTK inhibitor HCI-1401

Preclinical evidence that ET-B receptor agonism slows Alzheimer’s Disease progression

Hetero launches biosimilar rituximab in India

Antisense therapy proved effective in reducing triglyceride levels

Cold Genesys secures funding for immunotherapy trials

Sanofi and Evotec to collaborate on beta-cell-targeting therapies for diabetes

Dr. Reddy's to market three Amgen products in India

AstraZeneca discloses DPP1 inhibitors

Sunshine Lake patents HCV NS5A inhibitors

Cellceutix begins phase II trial of Prurisol for psoriasis

Lundbeck joins Global Alzheimer's Platform

Antiva Biosciences raises funds to advance lead compound for HPV

Allergan starts phase I trial of dry eye candidate AGN-232411

Varlitinib receives orphan drug designation from the FDA for cholangiocarcinoma

The FDA grants orphan drug designation to daratumumab for follicular lymphoma

New York State grants conditional approval for Rosetta Genomics' lung biomarker

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...